Muscle sample prepared for prion assay

Chemistry: analytical and immunological testing – Involving immune complex formed in liquid phase – Separation of immune complex from unbound antigen or antibody

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C435S001100, C435S007100, C435S007210, C435S023000, C435S287200, C435S380000, C435S962000, C530S412000, C530S419000, C436S517000, C436S524000, C436S528000, C436S534000, C436S536000, C436S538000, C436S017000, C436S166000, C436S174000, C436S175000, C436S177000

Reexamination Certificate

active

10211942

ABSTRACT:
A method of preparing a sample of muscle tissue and of assaying the prepared sample to determine the presence of prions in the sample is disclosed. The muscle tissue is homogenized and mixed with a complexing agent which forms a complex with a higher specific gravity than PrPSc, the complexing agent or other components of the homogenate. Gravity is then used (e.g. ultra centrifugation) to concentrate the complex and the concentrate is assayed to detect prions. The muscle tissue is preferably extracted from a muscle or group of muscles such as hind limb muscle which have a higher or more preferably the highest concentration of prions as compared to other muscle in the mammal.

REFERENCES:
patent: 5891641 (1999-04-01), Prusiner et al.
patent: 5977324 (1999-11-01), Prusiner et al.
patent: 6166187 (2000-12-01), Prusiner et al.
patent: 2003/0208052 (2003-11-01), Prusiner et al.
patent: WO 99/42829 (1999-08-01), None
Wadsworth et al., Tissue distribution of protease resistant prion protein in variant Creutzfeldt-Jakob disease using a highly sensitive immunoblotting assay, The Lancet 358: 171-180 (Jul. 21, 2001).
Chiesa et al., Primary Myopathy and Accumulation of PrPSc-like molecules in peripheral tissues of transgenic mice expressing a prion protein insertional mutation, Neurobiology of Disease 8: 279-299 (May 3, 2001).
Westaway et al., Degeneration of skeletal muscle, peripheral nerves, and the central nervous system in transgenic mice expressing wild-type prion proteins, Cell 76 (1): 117-129 (Jan. 14, 1994).
Bosque et al., “Prions in Skeletal Muscle”PNAS99(6):3812-2817 (Mar. 19, 2002).
Chiesa et al., “Primary Myopathy and Accumulation of PrPSc-Like Molecules in Peripheral Tissues of Transgenic Mice Expressing a Prion Protein Insertional Mutation.”Neurobiology of Disease8:279-288 (2001).
Wadsworth et al., “Tissue distribution of protease resistant prion protein in variant Creutzfeldt-Jakob disease using a highly sensitive immunoblotting assay.”The Lancet358:171-170 (Jul. 21, 2001).
Bendheim, et al., “Nearly ubiquitous tissue distribution of the scrapie agent precursor protein,”Neurology, 42:149-156 (1992).
Bueler, et al., “Mice devoid of PrP are resistant to Scrapie”,Cell, 73:1339-1347 (1993).
Carp, “Transmission of scrapie by oral route: effect of gingival scarification,”Lancet, 1:170-171 (1982).
Eklund, et al., “Pathogenesis of scrapie virus infection in the mouse,”J. Infect. Dis., 117:15-22 (1967).
Hadlow, et al., “Virologic and neurohistologic finding in diary goats affected with natural scrapie,”Vet. Pathol., 17:187-199 (1980).
Horiuchi, et al., “A cellular form of prion protein (PrPC) exists in many non-neuronal tissues of sheep,”J. Gen. Virol., 76:2583-2587 (1995).
Prusiner, “Novel proteinaceous infectious particles cause scrapie”Science, 216:136-144 (1982).
Prusiner, et al., “Ablation of the prion protein (PrP) gene in mice prevents scrapie and facilitates production of anti-PrP antibodies,”Proc. Natl. Acad. Sci USA, 90:10608-10612 (1993).
Prusiner, et al., “Immunological and molecular biological studies of prion proteins in bovine spongiform encephalopathy,”J. Infect. Dis., 167:602-613 (1993).
Scott, et al., “Compelling transgenetic evidence for transmission of bovine spongiform encephalopathy prions to humans,”Proc. Natl. Acad. Sci. USA, 96:15137-15142 (1999).
Spraker, et al., “Spongiform encephalopathy in free-ranging mule deer (Odocoileus hemionus), white-tailed deer (Odocoileus virginianus) Rocky Mountainer elk (Cervus elaphus nelsoni) in northcentral Colorado,”J. Wildl. Dis., 33:1-6 (1997).
Will, et al., “Deaths from variant Creutzfeldt-Jakob disease,”Lancet, 353:979 (1999).
Askanas, Valerie et al., “Prion protein is strongly immunolocalized at the postsynaptic domain of human normal neuromuscular junctions”Neuroscience Letters, vol. 159, No. 1-2 (1993) pp. 111-114.
Bendheim, P.E. et al., “Nearly Ubiquitous Tissue Distribution of the Scrapie Agent Precursor Protein”Neurology, Lippincott Williams & Wilkins, Philadelphia, US, vol. 42, (Jan. 1992), pp. 149-156.
Horiuchi, M. et al., “A Cellular Form of Prion Protein (PRPC) Exists in Many Non-Neuronaltissues of Sheep”Journal of General Virology, Society for General Microbiology, Spencers Wood, GB, vol. 76 (1995) pp. 2583-2587.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Muscle sample prepared for prion assay does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Muscle sample prepared for prion assay, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Muscle sample prepared for prion assay will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3823692

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.